Industry 4.0 in the Pharmaceutical Industry Image

Industry 4.0 in the Pharmaceutical Industry

Purchase

Actionable Benefits

  • Provides a holistic overview of the pharmaceutical industry to reveal investment priorities.
  • Understand the short and mid-term market impacts of COVID-19 on pharmaceutical manufacturers’ technology investments.
  • Identify use cases that are driving growth in pharmaceutical manufacturers’ adoption of Industry 4.0 technologies.
  • Map the progress made by pharmaceutical clients regarding the utilization of Industry 4.0 technologies on ABI Research’s Digital Maturity Model. 

Critical Questions Answered

  • What are the current and future trends concerning technology adoption by pharmaceutical manufacturers?
  • What is the influence of regulators both in terms of compliance and their encouragement of investments in digital technologies?
  • What issues inhibit pharmaceutical manufacturers to invest in digital technologies and potential ways they could be overcome?
  • Who are some of technology suppliers that focus on addressing the specific needs of pharmaceutical manufacturers?

Research Highlights

  • Strategic recommendations about engaging with pharmaceutical manufacturers.
  • A detailed assessment of spend by pharmaceutical manufacturers on digital technologies through 2030.
  • Case studies covering how manufacturers have utilized digital technologies.
  • Understand the types of suppliers looking to help pharmaceutical manufacturers digitize processes and optimize production.

Who Should Read This?

  • Strategists responsible for improving how their organizations engage with the pharmaceutical industry.
  • System integrators that need to evaluate potential solutions at their client sites.
  • Marketing leaders looking to understand adoption rates for digital technologies.
  • Digital leaders at pharmaceutical firms looking to obtain insights covering how digital technologies can support the manufacturing of drugs and vaccines.

Table of Contents

1. EXECUTIVE SUMMARY

2. INTRODUCTION TO THE PHARMACEUTICAL MARKET

2.1. Regulatory Environment

3. COMPONENTS OF A DIGITAL STRATEGY IN PHARMA MANUFACTURING

4. STRATEGIC GUIDANCE/RECOMMENDATIONS FOR STAKEHOLDERS

4.1. For Pharmaceutical Manufacturers
4.2. For Technology Suppliers

5. INDUSTRY 4.0 DRIVERS

6. INDUSTRY 4.0 INHIBITORS

7. MARKET DEVELOPMENTS

8. FORECASTS

9. PHARMACEUTICAL MANUFACTURING SUPPLIER ECOSYSTEM

9.1. Digitizing Processes
9.2. Optimizing Production Processes